CDC

Merck pneumonia vaccine endorsed by CDC panel (NYSE:MRK)

Erik S. Lesser/Getty Images News Merck (NYSE:MRK) announced that a group of independent advisors to the U.S. CDC unanimously voted to recommend its newly approved pneumonia vaccine, Capvaxive, for adults aged 65 years and older. The decision comes days after the FDA approved the 21-valent conjugate vaccine for preventing invasiveContinue Reading

GSK, Pfizer decline as CDC advisors recommend narrower age range for RSV shots (NYSE:GSK)

In: Finance

Hailshadow GSK (NYSE:GSK) and Pfizer (NYSE:PFE) both declined in Wednesday trading after the CDC’s Advisory Committee on Immunization Practices recommended an age range for respiratory syncytial virus (RSV) vaccines that wasn’t as broad as drugmakers would have liked. GSK closed down ~3.6%, while Pfizer lost 2%. The panel voted thatContinue Reading

Merck pneumonia vaccine endorsed by CDC panel (NYSE:MRK)

Generative AI for agriculture: How Agmatix is improving agriculture with Amazon Bedrock | Amazon Web Services

Generate financial industry-specific insights using generative AI and in-context fine-tuning | Amazon Web Services